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Abstract
Background Anastomotic complications following colorectal surgery are associated with significant morbidity and mortality. 
For patients in whom systemic sepsis is absent or well controlled, minimal access techniques, such as endoscopic therapies, 
are being increasingly employed to reduce the morbidity of surgical re-intervention. In this review, we aim to assess the util-
ity of endoscopic management in the acute setting of colorectal anastomotic complications, focusing on anastomotic leak.
Method A literature search was performed for published full text articles using the PubMed, Cochrane and Scopus data-
bases using the search criteria string “colorectal anastomotic (“leak” OR “bleed”), “endoscopy”, endoscopic management”. 
Additional papers were detected by scanning the references of relevant papers. Data were extracted from each study by two 
authors onto a dedicated pro-forma. Given the nature of the data extracted, no meta-analysis was performed.
Results A total of 89 papers were identified, 16 of which were included in this review; an additional 14 papers were obtained 
from reference searches. In patients who are not physiologically compromised, there are promising data regarding the sal-
vage rate of stents, over-the-scope endoscopic clips, vacuum therapy and fibrin glue in the early management of colorectal 
anastomotic leak. There is no consensus regarding the optimal approach, and data to assist the physician in patient selec-
tion are lacking. Whilst data on salvage (i.e. healing and avoidance of surgery) are well understood, no data on functional 
outcomes are reported.
Conclusion Endoscopic therapy in the management of stable patients with colorectal anastomotic leaks appears safe and 
in selected patients is associated with high rates of technical success. Challenges remain in selecting the most appropriate 
strategy, patient selection, and understanding the functional and long-term sequelae of this approach. Further evidence from 
large prospective cohort studies are needed to further evaluate the role of these novel strategies.
Keywords Colorectal · Anastomotic leak · Stricture · Colonoscopy · Endoscopy
There are 41,000 patients diagnosed with colorectal can-
cer in the UK each year [1]. Many of these patients will 
undergo surgical resection with the formation of an anas-
tomosis, often at the greatest risk below the pelvic brim 
for rectal cancer resection. Despite advances in surgical 
technique, anastomotic complications continue to be asso-
ciated with a significant rate of morbidity and mortality; 
including potential permanent stoma formation, increased 
length of hospital stay [2], increased local recurrence [3] 
and significant financial implications for an ever strained 
health service. Anastomotic leaks occur in 5–15% of patients 
following a colorectal anastomosis [4–6] and are more fre-
quently observed in those of a male sex, a BMI > 35 kg/
m2, those who have had pre-operative chemo-radiation, or 
patients with tumours > 5 cm in size or within 7 cm of the 
anal verge [7]. Intraoperative assessment of anastomotic 
integrity is now common practice, whether by an air leak 
test, endoscopy, intraoperative dye test or laser fluorescence 
angiography. However, techniques to then subsequently 
reduce the leak rate have little evidence, including transanal 
decompression devices, intraluminal barriers or extralumi-
nal devices such as tissue bolstering. The use of drains and 
mechanical bowel preparation also continues to be a subject 
of debate [8, 9].
and Other Interventional Techniques 
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In patients who are physiologically unwell, the tradi-
tional treatment for the disruption of a colorectal anas-
tomosis is to return to theatre for lavage and take down 
of the anastomosis; however, this has increasingly been 
the subject of some debate [10, 11]. Whilst this removes 
the source of sepsis, patients undergo a second major 
operation carrying a morbidity in excess of 50% [11]. 
The “divert and drain” approach of a defunctioning loop 
ileostomy and pelvic drainage, whilst leaving the anasto-
mosis intact, has proved increasingly popular with a suc-
cess rate ranging upwards from 54% [12]. Leaving the 
primary anastomosis intact avoids more complex dissec-
tion in inflamed tissue planes and has been shown to be 
associated with a threefold increase in the likelihood of 
patients achieving stoma reversal [13]. Conversely, salvag-
ing an anastomosis in this manner may predispose patients 
to chronic pelvic sepsis and poor functional outcomes [14, 
15].
There has been increasing interest in methods of anasto-
motic salvage which do not require re-entry into the abdomi-
nal cavity. In selected patients, endoscopy may provide the 
advantage of a diagnostic element with several options for 
safe therapeutic management without precluding second line 
invasive surgical options. In this review, we aim to assess 
the utility of endoscopic management in the acute setting 
of colorectal anastomotic complications, focusing on anas-
tomotic leak.
Methods
A literature search was performed for published full text 
articles using the PubMed, Cochrane and Scopus databases 
using the search criteria string “colorectal anastomotic 
(“leak” OR “bleed”), “endoscopy”, endoscopic manage-
ment”. Additional papers were detected by scanning the 
references of relevant papers. Search results were initially 
included due to a relevant title, and those papers were then 
read through in full. All study types were included although 
the search was limited to papers with a focus on colorectal 
surgery. Exclusion criteria included those reporting only on 
anastomoses of the upper gastro-intestinal tract. Papers were 
reviewed using the Covidence™ system (http://www.covid 
ence.org) to enable reviews to take place methodically.
Once eligible papers were identified, a search was per-
formed to exclude duplicated results or duplicated data 
sets to produce the final list of papers included. Data were 
extracted from each study by two authors onto a dedicated 
pro-forma. Given the heterogenous nature of the data 
extracted, no meta-analysis was performed. As secondary 
research, no institutional approval was required within the 
United Kingdom.
Results
A total of 89 papers were identified, 16 of which were 
included in this review; additional 21 papers were obtained 
from reference searches. These include 3 systematic 
reviews, 4 cohort studies, 28 case series, 1 case report and 
1 pilot study. There were no randomised trials. Figure 1 
shows the PRISMA flow diagram. Nine papers included 
patients with anastomotic leaks managed using stents, 
seven endoscopic clips, 14 using vacuum therapy, three 
fibrin glue and four on multi-modal management of anas-
tomotic bleeding. Other papers reviewing a combination 
of therapies have been referenced throughout.
Stenting
Self-expanding metal stents (SEMS) have been considered 
for the use of colorectal surgical complications for many 
years. Stents can vary in terms of their silicon coverage 
(fully, partially, uncovered) and material (metal or biode-
gradable). The aim with anastomotic leak is to place the 
stent across the defect to prevent communication between 
the lumen and extraluminal space to protect the patient 
from sepsis during tissue growth [16].
There were a total of nine case series or cohort stud-
ies including 58 patients who had their anastomotic leaks 
managed with stents (Table 1) [5, 17–24]. Long-term sal-
vage rates were reported between 50 and 100%, which in 
most cases was defined as evidence of closure at time of 
removal of the stent or follow-up endoscopy. The larg-
est cohort study to date focusing on the use of stents for 
anastomotic leak was by Lamazza et al. [22] This study 
included 22 patients with an anastomotic defect greater 
than 30% of the circumference, which was confirmed on 
a low-pressure gastrografin enema study. 68% of their 
patients had a defunctioning stoma after the diagnosis 
of leak and 27% of patients had to undergo repeat stent-
ing after spontaneous expulsion of the stent. Their over-
all anastomotic salvage rate was 86.4%, with all of those 
patients achieving stoma reversal and only two requiring 
further surgery for a chronic fistula. They reported no 
problems with anorectal pain or tenesmus.
Chi et  al. experienced similarly promising salvage 
results in their case series of 12 patients, but different 
findings with regard to local stent symptoms [19]. Stent 
migration was experienced in 66.7%, anorectal pain in 
58.3% and faecal incontinence in 25.0%; however, clini-
cal success without reoperation was achieved in 83.3% of 
patients.
Chopra et  al. [5] retrospectively compared the out-
comes of 20 patients following a colorectal anastomotic 
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leak managed with either surgical vs. endoscopic interven-
tion. Seven underwent reoperation in the form of a surgical 
repair of the anastomosis or the creation of a stoma, and of 
the 13 patients managed with endoscopy six were stented, 
five had vacuum therapy and two received fibrin to close 
the defect. Although this was a small study, they found 
significant improvement in the healing time of the anas-
tomosis in the group who were managed with endoscopy 
(105 days endoscopic group, 173 days operative group) 
and also in the proportion of patients who achieved long-
term intestinal continuity (77% endoscopic group, 57% 
operative group). All six of their patients who were stented 
achieved anastomotic healing and salvage.
DiMaio et al. presented their case series in 2012 focusing 
on covered self-expanding metal stents in the non-operative 
management of post-operative colorectal anastomotic leaks 
[21]. They included defects less than 5 cm from the anal 
verge, and concurrent use of clips or fibrin glue was left to 
the discretion of the endoscopist. Five patients underwent 
the procedure, all as a result of a rectal anastomotic leak. 
Deployment was achieved in all, with fibrin glue used in 
three. Stents were removed at a median of 20 days (range 
7–78), with one patient experiencing spontaneous expulsion. 
Complete defect resolution was achieved in two patients, 
with a further two patients experiencing a small residual 
fistula but with no requirement for further treatment. One 
patient was returned to theatre for formation of a defunction-
ing stoma due to a persistent symptomatic fistula.
A systematic review of the use of stents for colorectal 
anastomotic complications including was published by 
Arezzo et al. in 2017 [16]. Thirty-two studies were included 
(one multi-centre study) including 223 patients. Indications 
for stent placement included anastomotic leak (18 patients), 
fistula formation (20 patients) and luminal stricture (185 
patients) in the rectum or sigmoid colon. The overall esti-
mated early success rate was reported as 73.3%, with 9.3% of 
Fig. 1  PRISMA diagram
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patients requiring surgical intervention. Longer term success 
was achieved in 57.3% of patients. The rate of stent migra-
tion was 41.5%, persisting dehiscence 25.5%, persisting 
stenosis 44.0% and 26.0% required secondary balloon dila-
tation. The authors concluded that a stent could be consid-
ered in the early post-operative management of anastomotic 
complications in patients who have minimal risk of sepsis, 
although safety and efficacy needed to be further established.
Overall although there are limited data on the use of stents 
for colonic and rectal anastomotic leaks, the data appear 
promising with most patients achieving healing of the defect. 
Although local symptoms of pain and tenesmus in some stud-
ies are common, this could possibly be overcome by ensuring 
stent placement at least 5 cm from the anal verge. Migration 
of the stent is a common problem throughout the studies. 
Although this is expected due to colonic peristalsis and the 
use of covered stents, it incurs extra costs when the stent 
is replaced and creates further interventions for the patient. 
Very few studies stated how they selected their patients for 
stenting over surgery, and the defects varied from 30 to 100% 
of the anastomotic circumference. In addition to this, faecal 
diversion varied greatly and overall was 56.4% (22/39) in the 
studies that reported it. It is therefore difficult to recommend 
which cohort this technique would be suitable for.
Endoscopic clips
A reliable endoscopic clipping technique for anastomotic 
leak, iatrogenic perforations and staple line bleeding has 
been under development for several years. The efficacy 
of an initial ‘through-the-scope clip’ (TTSC) system was 
limited by the width of the clip branches and the limited 
pressure that could be applied to the tissue, often requiring 
multiple clips to close one small defect. Evidence was often 
anecdotal, and its successful translation into clinical practice 
limited [25]. The ‘over-the-scope clip’ (OTSC) system, first 
described in 2007 for the management of acute gastro-intes-
tinal bleeds or perforations, has had much more encouraging 
results due to its ability to grasp larger amounts of tissue and 
create a higher compression force [26].
There were 7 case series and cohort studies with a total 
of 62 patients having clips utilised to close a defect in the 
colonic wall or anastomosis [23, 25–30]. A summary of the 
available evidence is shown in Table 2. Overall, the success 
rate of over-the-scope clips was reported between 57.1 and 
100%, including patients who were clipped post-endoscopic 
iatrogenic perforation or post-operative anastomotic leaks.
One of the primary papers reporting this technique in 
2007 examined 11 patients, three with small perforations 
post-polyp excision and eight with acute bleeding [26]. All 
eight patients achieved haemostasis with the application 
of only one clip, and only one iatrogenic perforation went 
on to require further endoscopic intervention in the form 
of a stent. All patients avoided the morbidity associated 
with surgical intervention, although all defects were small 
at less than 2 cm.
Manta et al. have since published a prospectively col-
lected case series of 76 endoscopically managed post-
surgical leaks involving the GI tract over a 5-year period, 
including 24 following rectal resection or colectomy [23]. 
17 cases were managed with OTSC, of which four were 
also stented. The mean (range) size of the defect managed 
solely with over-the-scope clips was 12 (5–25) mm, with 
those also requiring a stent having defects measuring up to 
50 mm. This technique had a 64.7% success rate, defined 
as complete radiological and/or endoscopic resolution at 
follow-up, with five patients undergoing open re-interven-
tion and one having laparoscopic suturing. In addition to 
this, two patients had radiological drains placed to manage 
local sepsis.
Mennigen et al. published the results of a case series at 
their tertiary referral centre in 201325. Clips were used in 14 
patients with anastomotic leak, three of which were rectal. 
Overall success of the technique, both endoscopically and 
fluoroscopically, at the time of closure and long-term follow-
up in all 14 patients was reported to be 79%. Kirschniak et al. 
published a case series in 2011 of 50 patients using over-
the-scope clips [28]; 15 required intervention for colonic 
bleeding (one from a stapled colorectal anastomosis) and 
four for free colonic perforations post-polypectomy. Primary 
haemostasis and colonic closure were achieved in all cases 
with no adverse outcomes. A prospective multi-centre cohort 
study was published in 2012 by the CLIPPER study group 
examining the use of OTSC specifically for iatrogenic perfo-
rations post-endoscopic intervention [30]. In the 13 patients 
with colonic perforations, a 92% closure rate was reported. 
Despite promising results in a multi-centre setting, anasto-
motic complications were not included.
Arezzo et al. published a case series in 2012, collecting 
data over a 42-month period for 14 patients managed with 
OTSC for an anastomotic leak or fistula of the colon or rec-
tum within 60 days of surgery [27]. The mean diameter of 
the defect was 9.1 mm (range 5–12 mm). Eight patients had 
acute anastomotic leaks and six had chronic leaks, two of 
these patients had an established colo-cutaneous fistulae and 
a further two had a rectovaginal fistula. Three patients with 
chronic anastomotic leaks also required vacuum therapy to 
drain the abscess cavity, and one patient had a stent placed 
at the time of clipping. Overall success rates of complete 
closure, as assessed by soluble contrast through the work-
ing channel of the scope, were 86% and 83% in acute and 
chronic cases, respectively, with no clip associated compli-
cations. One patient required surgical intervention, giving 
an endoscopic salvage rate of 92.9%. Encouraging results 
have also been reported in an individual case series of two 
patients [29].
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Endoscopic clipping has an established role in haemosta-
sis, and now over-the-scope clips appear to have a potential 
role in managing colonic defects. The use of these clips, 
however, appear to be limited to small defects of under 2 cm 
and were more successful in closing acute breaches, iatro-
genic perforations or acute leaks rather than chronic fistulae.
Vacuum‑assisted closure
Vacuum-assisted wound closure (VAC) devices, in par-
ticular the Endo-SPONGE® (B. Braun Medical Ltd) is an 
open-cell, cylindrical polyurethane sponge connected to a 
drainage tube linked to a vacuum system exerting constant 
suction [31]. VAC therapy promotes healing of wounds by 
enhancing formation of granulation tissue, reducing oedema, 
increasing vascularity and decreasing bacterial colonisation 
[32]. Their use is well established for post-operative wound 
care and is being increasingly considered as a non-surgical 
alternative in the management of anastomotic leaks.
A total of 14 case series or cohort studies consisting of 
197 patients were reviewed [5, 23, 31–42]. A summary 
of these are shown in Table 3. The overall rate of anasto-
motic salvage in patients without generalised peritonitis 
and deemed suitable for vacuum therapy was 88.8% (range 
66.6–100%), with very few adverse outcomes reported.
The first study detailing its use for this indication was 
published in 2008 by Weidenhagen et al., examining the 
results of endoscopic vacuum therapy over a 2-year period in 
34 patients with an anastomotic leak following low anterior 
resection [42]. 29 patients were deemed eligible to continue 
treatment (giving informed consent, with no development 
of secondary complications), 21 of whom had covering sto-
mas at the time of initial surgery and a further four requir-
ing faecal diversion alongside VAC therapy. Two patients 
required return to theatre after commencement of VAC due 
to anastomotic necrosis. Of these 29 patients, definitive heal-
ing was achieved in 90.3% of patients including nine (31%) 
requiring fibrin injections to close a resulting small defect. 
Ambulatory management was possible in 86.2%, with minor 
rectal bleeding commonly reported post-sponge change due 
to increased vascularity in granulation tissue.
Kuehn et al. published a further case series of 41 patients 
in 2016, 20 of whom suffered from a colorectal anastomotic 
leak [34]. Median (range) therapy duration was 23 (2–109) 
days with a mean (range) of 7 (2–37) sponge changes per 
patient. The anastomotic salvage rate was 90%, with only 
two patients requiring return to theatre for exteriorisation 
of a necrotic anastomosis. Similarly, Strangio et al. pub-
lished a single centre series in Milan in 2015 [39]. Of 296 
patients undergoing colorectal surgery, 40 (13.4%) patients 
developed an anastomotic leak. Twenty-five of these leaks 
were managed with VAC therapy commencing after a 
median of 16 days post leak diagnosis, with a median of Ta
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nine applications per patient over 4 weeks. Complete healing 
of the leak occurred in 88% of patients, with the remaining 
three patients developing further complications requiring 
surgical intervention. The only study to consider the timing 
of intervention was that of Van Koperen et al. who demon-
strated that earlier (less than 6 weeks) use of VAC therapy 
resulted in greater success of salvaging the anastomosis 
(75% vs. 38%) [41].
Von Bernstorff et al. [40] conducted a study of 26 patients 
with rectal anastomotic leaks receiving endoscopic vacuum 
therapy and reported an overall successful closure of cav-
ity rate of 88.5%. In those who underwent neoadjuvant 
chemoradiotherapy, there was a significantly longer time 
to leak diagnosis, (14.7 vs. 6.6 days, p < 0.008), longer 
mean duration of treatment (31.6 vs. 12.3 days, p < 0.001), 
more sponge changes (8 vs. 3, p < 0.035) and longer time 
to achieve complete closure of the leak (30.4 vs. 71.1 days, 
p < 0.01).
Of the studies that reported the prevalence of stoma crea-
tion, 82% (142/173) of patients had faecal diversion either 
during their primary surgery (88%) or after the diagnosis 
of an anastomotic leak (17%). This was an inclusion crite-
ria in some studies due to concerns of faeces blocking the 
vacuum system and preventing the therapy from working 
[5, 34]. However, Strangio et al. 39 successfully managed 
12 patients, Bernstoff et al. [40] managed eight patients, and 
Riss et al. [37] managed six patients with VAC therapy with-
out proximal faecal diversion, therefore suggesting that the 
lack of a defunctioning stoma is not necessarily an exclu-
sion criteria for this therapy and future studies should help 
clarify this.
The use of vacuum therapy to drain peri-anastomotic 
abscesses and aid healing of the defects is very encouraging. 
In common with the other techniques, it is limited to patients 
who are haemodynamically stable and do not have gener-
alised peritonitis, but also to those with an extraperitoneal 
anastomosis. This technique appears to be safe with mini-
mal local symptoms or complications and in some cases has 
been used in the outpatient setting. There is a high long-term 
rate of intestinal continuity of up to 92% [36] and therefore 
could prove to be a solution to the difficulty of percutaneous 
drainage in this area. An important consideration, however, 
is the cost of this repeated procedure as the median number 
of sponge changes were between 5.4 and 11.4.
Endoscopic drainage of intra‑abdominal sepsis
A pilot study published by Blot et al. in 2016 examined 
the feasibility of endoscopic-guided double-pigtail stents 
(DPS) in the management of colorectal anastomotic leaks 
not associated with systemic sepsis [43] The defect in the 
anastomotic line was initially dilated to allow maximum 
drainage of intra-abdominal drainage before the drain 
was secured. Placement was confirmed with a CT scan, 
and repeated at 6-week intervals until resolution of the 
abscess. Over a 3-year period nine patients were managed 
with DPS alone, five with radiological intra-abdominal 
drainage followed by DPS and ten with exclusively radio-
logical drainage (RD). All patients undergoing RD alone 
required no further intervention, with all patients with a 
defunctioning stoma at the time of primary surgery suc-
cessfully progressing to closure. The overall success of 
endoscopic management was 78.5%, and the median 
number of endoscopic procedures was two. One patient 
required concurrent expandable stent placement and two 
patients required progression to laparotomy for take down 
of the anastomosis. Of interest, of the four patients requir-
ing adjuvant chemotherapy all were able to undergo their 
treatment with the DPS in situ.
Fibrin glue
Although fibrin glue has been most extensively investi-
gated in the use of complex perianal fistulae [44], it has 
also become a novel option for the management of anasto-
motic leak either alone or as combination therapy. A total 
of three studies focusing on the use of fibrin glue for the 
closure of anastomotic defects were reviewed including 
22 patients [5, 45, 46]. A summary of available evidence 
is shown in Table 4. Lippert et al. reported their retro-
spective case series in 2011 of patients undergoing fibrin 
glue repair endoscopically for fistulae and anastomotic 
leaks [46]. Of the 47 post-operative cases examined, 14 
underwent a colonic or rectal resection with an anastomo-
sis. Success, defined as no further management interven-
tions, was achieved for 75% in the colon, and 16.7% in the 
rectum. Septic complications were reported in 28.8% of 
the entire cohort, and 34.6% required secondary surgical 
intervention. No local recurrence was reported, however, 
follow-up was limited.
Weidenhagen et al. reported their series of 34 patients 
who had an anastomotic leak following anterior resection, 
primarily treating suitable patients with vacuum-assisted 
therapy [42]. Once the cavity was less than 0.5 × 1 cm , the 
use of the vacuum ceased and in nine of their patients they 
used fibrin glue to definitively closure the tissue defect. 
96.6% of their patients achieved closure of the anastomotic 
defect, although it is not stated what contribution the fibrin 
had to this success. Del Rio et al. published a case series of 
13 patients who were treated with fibrin glue, six of whom 
had a rectal anastomosis [45]. The leaks were detected on 
post-operative day 3–9, the anastomotic defects measured 
2–5 mm, and each patient underwent a mean of 3.3 treat-
ments. All patients achieved closure of the defect as con-
firmed by radiological examination.
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Multi‑modal therapy for anastomotic bleeding
Anastomotic bleeding can present as a severe bleed in 
approximately 1% of patients [47], and a single significant 
episode in up to 6% of patients [48, 49]. With the consid-
erations of preserving the anastomosis and achieving safe 
endoscopy due to active bleeding, management can be chal-
lenging. A summary of the available evidence is shown in 
Table 5.
Besson et al. reported their case series of 729 patients 
undergoing either a laparoscopic or open elective left hemi-
colectomy over a 9-year time frame [48]. Post-operative 
bleeding was experienced in 6.4% of patients, of which 
97.8% had a stapled anastomosis. The development of an 
anastomotic leak was slightly greater in this cohort (8.5% vs. 
6.5%). Of the 47 patients with bleeding, 10 resolved sponta-
neously without need for investigation, nine underwent diag-
nostic endoscopy but required no intervention, 10 had clips 
placed, 11 had injection of a mucosal sclerosant and seven 
required both haemostatic techniques. No patients required 
further endoscopic intervention, however, five returned to 
theatre due to a significant anastomotic defect demonstrated 
at the time of diagnostic endoscopy.
Similar incidence rates are reported across the literature 
with equal success. Malik et al. reported a post-operative 
bleeding rate of 0.8%, with three patients in their case 
series undergoing endoscopic therapy (adrenaline injec-
tion, diathermy or clipping) achieving control and salvage 
of the anastomosis in all cases [50]. Martinez-Serrano et al. 
reported a post-operative bleed rate of 0.5% from their 
cohort of 1389 patients undergoing elective laparoscopic 
or open resection [51]. In these seven patients, endoscopic 
anastomotic washout with normal saline was performed and 
in six patients the bleeding ceased (85.7%); only one patient 
had to return to theatre for reconstruction of the anastomosis.
Discussion
It is well established that anastomotic complications have 
a significant impact on patient morbidity and mortality, as 
well as potentially delaying the commencement of adjuvant 
chemotherapy and increasing the risk of local recurrence 
[53]. Timely management is also important, as prolonged 
sepsis and fibrosis has been associated with impaired long-
term compliance and therefore function of the neo-rectum 
[14, 15]. It is clear from the evidence we have reviewed that 
endoscopic management using stents, clips, vacuum ther-
apy or fibrin glue may negate the requirement for surgery in 
selected patients suffering from colorectal anastomotic leak.
The placement of covered stents provides a feasible, rela-
tively low risk alternative to immediate surgical intervention. 
The subsequent progression to surgery in the acute setting Ta
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has been reported to be less than 10% [16]. Their use is not 
suitable, however, for those patients with systemic sepsis, or 
for an anastomosis encroaching on the anal verge. There is a 
high stent migration rate and reported side effects of discom-
fort or tenesmus. We can draw encouraging evidence from 
the existing literature for OTSC, in particular the low risk 
associated with the procedure compared to the morbidity of 
re-intervention. The evidence base, however, lies predomi-
nantly in upper gastro-intestinal bleeding and small defects 
(< 2 cm) from iatrogenic perforations. Evidence for their use 
in the management of colorectal anastomotic leaks is grow-
ing. Closure of anastomotic defects following the applica-
tion of endoscopic vacuum therapy has a reported success 
rate of up to 92% [33]. Numbers in individual studies do, 
however, remain small and studies are often single centre. 
Pre-interventional imaging and understanding of the local 
anatomy are integral for establishing the approach, in terms 
of number and sizing of sponges. Cavity size has not been 
reported as a contraindication with some centres using up to 
three sponges in cavities measuring 20 cm [42]. Concerns 
for this technique lie in the frequency of sponge changes 
(every 2–4 days) often requiring sedation or anaesthesia. 
The shorter healing time, avoidance of salvage surgery and 
the potential for up to 86% of patients to be ambulatory may 
well negate the additional treatment costs [41, 42]. Compli-
cations of bleeding, circumferential anastomotic breakdown 
and stricture requiring dilatation are uncommon but have all 
been reported [17, 41, 42]. The use of fibrin glue in rectal 
anastomotic insufficiency has been reported with varying 
success. Its role appears to be most suitable in patients with 
small defects [45], or in combination with other treatments 
such as vacuum therapy [42].
There are little data in any of the studies to assist the 
physician in selecting patients for endoscopic salvage, 
beyond the starting point of physiological stability. Selec-
tion of the particular endoscopic strategy is most likely to 
be determined by local expertise. Accepting the small evi-
dence base for fibrin glue, this is most likely appropriate for 
very small defects or as an adjunct to other therapies when 
a small defect remains. One has to consider the possibility 
that defects of this size may heal with conservative treatment 
alone. Most of the evidence for OTSC is in the manage-
ment of small iatrogenic perforations, and this technique 
will similarly lend itself to small defects in an otherwise 
healthy anastomosis. Placement of a SEMS in the colon is 
most commonly performed as a combined endoscopic-fluor-
oscopic procedure, and therefore requires availability of two 
operators and an interventional radiology suite. The logisti-
cal difficulties of vacuum therapy, specifically the multiple 
and frequent sponge changes, have already been discussed. 
Ultimately if a patient is felt suitable for endoscopic sal-
vage of a deficient colorectal anastomosis, an individualised 
treatment plan is required. This must take into account local 
expertise, availability of specialist equipment, and patient 
Table 5  Multi-modal endoscopic management of anastomotic bleeding
Ref Study type Level of 
defect
Intervention Cohort size Long-term 
salvage
Surgical inter-
vention
Secondary 
unplanned 
endoscopic 
intervention
Other endpoints 
described/com-
plications
Besson [48] Case series Colorectal 
(lap or open 
left hemi-
colectomy)
10—None 
required
9—Diagnostic 
endo
10—OTSC
11—Injection 
sclerosant
7—
OTSC + injec-
tion
47 89.40% 10.6% due 
to size of 
anastomotic 
defect
0% –
Malik [50] Case series Colonic
Colorectal
Ileocolic
1—Diathermy 
and injection 
adrenaline
1—Injection 
adrenaline
1—OTSC
6 50% 50% 16.7% further 
endoscopy 
for dia-
thermy
–
Martinez-Ser-
rano [51]
Case series Colorectal 7—Anasto-
motic washout 
(saline)
7 85.70% 14.30% 0% –
Perez [52] Case report Colorectal Washout and 
injection of 
adrenaline
1 100% 0% 0% –
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factors such as the anatomy of the anastomotic defect, co-
morbidity and ability to tolerate failure of therapy.
Whilst technical success and avoidance of re-operative 
surgery is clearly an advantageous starting point, we must 
consider the potential sequelae of endoscopic salvage both in 
terms of the risk of chronic pelvic sepsis and adverse func-
tional outcomes. Nesbakken et al. [15] directly compared 
the functional outcomes of 11 patients post anastomotic leak 
and subsequent stoma closure with 11 patients undergoing 
an uncomplicated low anterior resection. Patients who had 
experienced leakage had a trend towards reduced neorectal 
capacity (p = 0.04), faecal urgency (p = 0.09) and inconti-
nence (p = 0.06). Hallbook et al. [14] showed a similar pic-
ture in their study of 19 patients. Ashburn et al. [54] fol-
lowed up 52 patients with an anastomotic leak following 
restorative colorectal resection. They identified a signifi-
cantly worse SF-36 physical and mental component scale 
at 1 year. Kiely et al. [55] also showed reduced quality of 
life (p < 0.001) and increased daytime leakage in patients 
with chronic pelvic sepsis post-pouch formation. Mongin 
et al. [56] described poorer outcomes for lifestyle, coping/
behaviour, depression and self-perception for patients with 
an anastomotic leak post-sphincter saving total mesorectal 
excision on FIQL scores. As none of these papers focused 
upon endoscopic anastomotic salvage, it is vital that future 
studies which do strive to determine the relationship between 
technical success and functional outcomes.
In conclusion, endoscopic therapy in the management 
of stable patients with colorectal anastomotic leaks appears 
safe and in selected patients is associated with high rates of 
technical success. Challenges remain in selecting the most 
appropriate strategy and understanding the functional and 
long-term sequelae of this approach. There is little evidence 
available detailing functional outcomes after anastomotic 
salvage. Large prospective cohort studies are needed to fur-
ther evaluate the role of these novel strategies with a focus 
on patient reported outcome measures as the primary out-
come rather than technical success alone.
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